HIV treatment as prevention – launch of community consensus statement

On Thursday 27 February 2014, NAM and EATG, Europe’s community group for people with HIV, are launching a consensus statement, for endorsement by the HIV community, on using HIV treatment to prevent the transmission of HIV.

HIV treatment (antiretroviral therapy or ART) if taken as prescribed can effectively render people non-infectious. Reasons this has not already ended the HIV epidemic include lack of access to drugs; no global consensus on who should get them; ignorance about the prevention benefits of ART; stigma against people with HIV; the criminalisation and persecution of groups vulnerable to it; and people’s justifiable fear of compulsory or coercive HIV testing and treatment. These issues must be addressed if we are to end HIV.

Gus Cairns, Zoe Smith
NAM aidsmap
Read More

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below